Dental technology company Convergent Dental has entered into a new credit facility of $40 million with Trinity Capital. The company has drawn $20 million at closing and has the option to draw an additional $20 million, subject to the conditions under the agreement. The company has also received $10 million in equity financing led by existing investors Arboretum Ventures and Gund Investment, including $5 million of new equity and $5 million of existing investor notes converted to equity at the close. Convergent Dental’s flagship product is the Solea All-Tissue Dental Laser, an FDA-approved CO2 dental laser that allows dentists to perform virtually anesthesia-free, blood-free, and pain-free procedures.